Presentation + Paper
3 March 2022 Elucidating the neuropathophysiology of COVID-19 using quantum dot biomimetics of SARS-CoV-2
Author Affiliations +
Abstract
Quantum dots were encapsulated in polymeric phospholipid micelles conjugated to multiple ligands of SARS-CoV-2 spike protein to form fluorescent biomimetic nanoparticles for SARS-CoV-2 (COVID-QDs). Phosphatidylethanolaminepolyethylene glycol (PE:PEG) was appended with bis(4-methylphenyl)sulfone to form PE:PEG:bis-sulfone and selfassembled into micelles around CdSe/CdS core/shell quantum dots via thin-film rehydration. The introduction of the bissulfone group the surface of the micelle-encapsulated quantum dots provides multiple sites for conjugation to his-tagged SARS-CoV-2 spike protein via a bisalkylation mechanism. Based on the eluted unconjugated fraction, we estimate that an average of seven spike proteins are conjugated per COVID-QD. We treated an in-vitro model system for the neurovascular unit (NVU) with these COVID-QD constructs to investigate the COVID-QDs, and by proxy SARS-CoV-2, may modulate the NVU leading to the COVID-19 associated neuropathophysiology.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Wesley Chiang, Jennifer Urban, Angela Litzburg, Bradley Nilsson, Harris Gelbard, and Todd Krauss "Elucidating the neuropathophysiology of COVID-19 using quantum dot biomimetics of SARS-CoV-2", Proc. SPIE 11977, Colloidal Nanoparticles for Biomedical Applications XVII, 1197702 (3 March 2022); https://doi.org/10.1117/12.2609118
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Proteins

Quantum dots

Biomimetics

Luminescence

In vitro testing

Nanoparticles

Nervous system

Back to Top